Needham raised the firm’s price target on Globus Medical (GMED) to $117 from $114 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- Mathew Blackman Reiterates Buy on Globus Medical, Lifts Price Target to $115 on Durable Growth and Profitability Outlook
- Globus Medical price target lowered to $103 from $104 at Wells Fargo
- Globus Medical reports Q1 EPS $1.12, consensus 92c
- Globus Medical raises FY26 EPS view to $4.70-$4.80 from $4.40-$4.50
- GMED Earnings this Week: How Will it Perform?